Urologic Neoplasms
Information
- Disease name
- Urologic Neoplasms
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03595813 | Active, not recruiting | N/A | Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy | January 29, 2018 | July 2025 |
| NCT03288545 | Active, not recruiting | Phase 1/Phase 2 | A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer | October 11, 2017 | December 31, 2026 |
| NCT04579380 | Active, not recruiting | Phase 2 | Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations | January 11, 2021 | May 31, 2025 |
| NCT03091192 | Active, not recruiting | Phase 3 | Savolitinib vs. Sunitinib in MET-driven PRCC. | July 25, 2017 | December 31, 2024 |
| NCT00134186 | Completed | Phase 2 | Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer | ||
| NCT00151034 | Completed | Phase 2 | Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer | September 2000 | October 2007 |
| NCT00191971 | Completed | Phase 2 | 2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen | January 2004 | September 2006 |
| NCT00374868 | Completed | Phase 1/Phase 2 | Pemetrexed Plus Cisplatin Bi-Weekly, in Patients With Urothelial Cancer (Metastatic, Locally Advanced or Non-Resectable) | August 2006 | April 2008 |
| NCT01454089 | Completed | Phase 2 | A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer | October 2011 | November 2014 |
| NCT00001814 | Completed | Genetic Analysis of Inherited Urologic Malignant Disorders: Collection of Samples | April 1999 | January 2001 | |
| NCT00034177 | Completed | Phase 2 | Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium | April 2002 | September 2007 |
| NCT00034593 | Completed | Phase 2 | A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium | ||
| NCT00035061 | Completed | Phase 2 | A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium | ||
| NCT02780687 | Completed | Phase 2 | Afatinib Monotherapy in Patients With ERBB-deregulated Metastatic Urothelial Tract Carcinoma After Failure of Platinum Based Chemotherapy | June 9, 2016 | September 2, 2019 |
| NCT02891460 | Completed | N/A | Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients | January 2013 | March 2015 |
| NCT03010813 | Completed | N/A | A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery | December 2016 | October 2017 |
| NCT03081858 | Completed | Phase 1/Phase 2 | Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer | May 17, 2018 | August 5, 2021 |
| NCT03219333 | Completed | Phase 2 | A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer | October 8, 2017 | July 28, 2023 |
| NCT03458598 | Completed | N/A | Pre-Operative Single Shot Rectus Sheath Block | February 16, 2018 | February 5, 2019 |
| NCT03636256 | Completed | Phase 1/Phase 2 | Evaluation of NanoDoce® in Participants With Urothelial Carcinoma | April 2, 2019 | November 2, 2021 |
| NCT04052113 | Completed | Real World Evidence of PD-L1, TMB Prevalence and Efficacy of 1st Line Chemotherapy in These High or Low Population for Stage IV Urothelial Cancer | October 25, 2019 | March 23, 2020 | |
| NCT04213157 | Completed | Laparoscopic Partial Nephrectomy for cT1 Tumors | March 15, 2019 | November 10, 2019 | |
| NCT04649970 | Completed | Antegrade Double-J Stent Placement for the Treatment of Malignant Obstructive Uropathy | January 1, 2013 | February 2, 2020 | |
| NCT04933604 | Completed | LPN in Patients With High-complex Renal Tumors | September 1, 2019 | February 4, 2021 | |
| NCT05113134 | Completed | N/A | Transvaginal Versus Transabdominal Extraction of Laparoscopically-excised Specimen | March 2, 2015 | July 24, 2020 |
| NCT06353906 | Not yet recruiting | Phase 2 | Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer | June 14, 2024 | January 14, 2028 |
| NCT05935748 | Recruiting | Phase 2 | Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) | July 28, 2023 | September 2026 |
| NCT04442724 | Recruiting | N/A | Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy | July 1, 2020 | August 2024 |
| NCT05899361 | Recruiting | N/A | A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest | August 30, 2023 | December 25, 2026 |
| NCT06114940 | Recruiting | Phase 2 | Neoadjuvant Immune-based Combinations in Patients Undergoing Nephrectomy for Locally Advanced ccRCC | December 20, 2022 | December 31, 2025 |
| NCT06237920 | Recruiting | Phase 2 | Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab | February 19, 2024 | August 1, 2028 |
| NCT05887245 | Recruiting | Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial Nephrectomy | April 17, 2023 | January 1, 2030 | |
| NCT02386111 | Terminated | Phase 1 | A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma | May 2015 | November 3, 2017 |
| NCT00226954 | Terminated | Phase 2 | Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer | March 2003 | February 2009 |
| NCT02543645 | Terminated | Phase 1 | A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer | October 2015 | May 22, 2017 |
| NCT01155791 | Terminated | Phase 1 | Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer | April 2010 | October 2012 |
| NCT00384891 | Terminated | Phase 3 | Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer | February 2002 | December 2013 |
| NCT05308771 | Unknown status | N/A | To Investigate the Use of a New Syringe "Visual Pressure Control (VPC)" for Epidural Anesthesia in Children Surgery | March 25, 2022 | September 2022 |
| NCT04922047 | Unknown status | Phase 1/Phase 2 | Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01) | June 2021 | August 2023 |
| NCT05025930 | Unknown status | N/A | Evaluate the Safety and Effectiveness of the Endoscopic Surgical Instrument Control System (SP1000). | October 1, 2021 | September 30, 2023 |
| NCT05135520 | Unknown status | N/A | Transvaginal Versus Transabdominal Extraction of Laparoscopically-excised Kidney Specimen | November 29, 2021 | November 29, 2023 |
| NCT05135832 | Unknown status | N/A | Patient Reported Outcomes by Patients With Metastatic Renal Cell Carcinoma | December 13, 2021 | December 1, 2022 |
| NCT04644432 | Unknown status | Phase 2 | Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell Carcinoma | March 6, 2020 | September 6, 2022 |
| NCT04702347 | Unknown status | Genetic Testing in Upper Tract Urothelial Carcinoma (UTUC): the Epicheck Study | February 1, 2019 | February 28, 2021 | |
| NCT02254915 | Withdrawn | Phase 3 | SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I | ||
| NCT04630483 | Withdrawn | Platelet-lymphocyte and Neutrophil-lymphocyte Ratio in Patients Undergoing Cancer Surgery | November 23, 2020 | December 30, 2022 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D014571